855198-27-5 Usage
General Description
3-Bromo-5-ethoxybenzoic acid, also known as ethyl 3-bromo-5-carboxybenzoate, is a chemical compound with the molecular formula C9H9BrO4. It is a white to off-white crystalline powder that is soluble in organic solvents such as ethanol and acetone. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also utilized in the preparation of various fine chemicals and research compounds. The presence of the bromo and ethoxy groups on the benzene ring makes it useful in organic and medicinal chemistry for the development of new drugs and pharmaceutical products. 3-Bromo-5-ethoxybenzoic acid may also have potential applications in the field of materials science for the synthesis of advanced materials with specific properties.
Check Digit Verification of cas no
The CAS Registry Mumber 855198-27-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,5,1,9 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 855198-27:
(8*8)+(7*5)+(6*5)+(5*1)+(4*9)+(3*8)+(2*2)+(1*7)=205
205 % 10 = 5
So 855198-27-5 is a valid CAS Registry Number.
855198-27-5Relevant articles and documents
HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE
-
, (2017/01/26)
Disclosed are compounds having the formula: (I) wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and in treatment of diseases associated with BMP1, TLL1 and/or TLL2 activity.
4,5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES
-
Page/Page column 40, (2009/09/05)
The present invention relates to a compounds of formula I wherein R1, R1′, R2, R3, R4, X, Ar, and m are as defined in the specification and claims and pharmaceutically active acid addition salts thereof. Compounds of the invention have Asp2 (β-secretase, BACE 1 or Memapsin-2) inhibitory activity and are useful for the treatment of diseases characterized by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.